MorphoSys AG (NASDAQ:MOR)
| 5.46 Delayed Data As of 4:00pm ET |  +0.25 / +4.80%Today’s Change | 4.07 Today|||52-Week Range 12.45 | -42.04% Year-to-Date |
Latest MOR News | Press Releases
No recent news for MorphoSys AG.
Today’s Trading
| Previous close | 5.21 |
| Today’s open | 5.19 |
| Day’s range | 5.19 - 5.46 |
| Volume | 2,293 |
| Average volume (3 months) | 60,028 |
| Market cap | $751.4M |
Data as of 4:00pm ET, 10/04/2022
Growth & Valuation
| Earnings growth (last year) | -630.65% |
| Earnings growth (this year) | +25.23% |
| Earnings growth (next 5 years) | -31.22% |
| Revenue growth (last year) | -43.17% |
| P/E ratio | NM |
| Price/Sales | 5.93 |
| Price/Book | 2.70 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SRNESorrento Therapeutic... | +0.10 | +6.77% |
| CHRSCoherus BioSciences ... | +0.70 | +7.47% |
| RAPTRapt Therapeutics In... | +1.22 | +5.25% |
| ANABAnaptysBio Inc | +1.09 | +4.21% |
Data as of 4:00pm ET, 10/04/2022
Financials
| Next reporting date | November 17, 2022 |
| EPS forecast (this quarter) | -$0.65 |
| Annual revenue (last year) | $212.3M |
| Annual profit (last year) | -$608.1M |
| Net profit margin | -286.43% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Planegg, Bayern (bavaria) |
Forecasts
